DNA-directed RNA polymerase II subunit RPB1

BE0010600ProteinHumansPOLR2A

Catalytic core component of RNA polymerase II (Pol II), a DNA-dependent RNA polymerase which synthesizes mRNA precursors and many functional non-coding RNAs using the four ribonucleoside triphosphates as substrates (By similarity) (PubMed:23748380, PubMed:27193682, PubMed:30190596, PubMed:9852112). It is acted on by 3 drugs in DrugBank.

Gene name
POLR2A
UniProtKB entry
P24928Swiss-Prot
Cellular location
Nucleus
Residues / weight
1,970 residues · 217,204 Da
Also known as
2.7.7.6 · 3'-5' exoribonuclease · DNA-directed RNA polymerase II subunit A · DNA-directed RNA polymerase III largest subunit · POLR2

Resolves to

Pharmacology

What you can answer from here — as of October 31, 2023

3DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
1Clinical trialTrials of drugs acting on it, by phase and status
Sign in
15GO termsFunction, process and component, as structured annotations
Sign in
8Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on DNA-directed RNA polymerase II subunit RPB1, and which indications are they being tested in?

Create a free account or log in to explore the full data card.

Create Account